Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Alere Receives FDA Clearance for Respiratory Syncytial Virus MDx

Alere Receives FDA Clearance for Respiratory Syncytial Virus MDx

Aug 19, 2016
|
staff reporter

NEW YORK (GenomeWeb) – Alere announced today that it has received 510(k) clearance from the US Food and Drug Administration for a point-of-care isothermal nucleic acid amplification test that detects respiratory syncytial virus infection in children and adults from nasopharyngeal swab samples in 13 minutes or less.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

What's Popular?

In Molecular Diagnostics

  1. JP Morgan Healthcare Conference, Day 3: Exact Sciences, Luminex, Danaher, Siemens Healthineers, and More

  2. At JP Morgan Conference, Quidel CEO Discusses Plan to Enter OTC Infectious Disease Test Market

  3. JP Morgan Healthcare Conference 2021, Day One: Roche, Guardant, Hologic, Thermo Fisher, and More

  4. JP Morgan Healthcare Conference, Day 2: Qiagen, LabCorp, Abbott, and More

  5. BARDA Provides Additional Funding to DiaSorin Molecular for COVID-19 Tests

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.